Published in Blood on August 01, 1979
Molecular and cellular mechanisms of CLL: novel therapeutic approaches. Nat Rev Clin Oncol (2009) 1.64
Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type. Clin Exp Immunol (1982) 1.14
Characteristics and function of Fc receptors on human lymphocytes. Immunology (1982) 1.09
T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia. J Clin Invest (1982) 1.02
Evidence that T colony formation is a property of T mu (helper) lymphocytes. Clin Exp Immunol (1980) 0.98
Further evidence for T cell abnormalities in chronic lymphocytic leukaemia of the B cell type. Clin Exp Immunol (1983) 0.89
Reduced T lymphocyte colonies in B chronic lymphocytic leukaemia. III. Evidence of a proliferative abnormality of the T helper cell population. Clin Exp Immunol (1982) 0.79
T lymphocyte function in hairy cell leukaemia. Clin Exp Immunol (1980) 0.79
Functional and phenotypic heterogeneity of electrophoretically separated leukaemic B cells from patients with chronic lymphocytic leukaemia. Clin Exp Immunol (1985) 0.78
T cell subpopulations in CLL: methods of T cell enrichment artificially alter proportions of OKT4 and OKT8 positive cells. Clin Exp Immunol (1983) 0.78
Increased levels of soluble low-affinity Fc gamma receptors (IgG-binding factors) in the sera of tumour-bearing mice. Clin Exp Immunol (1992) 0.76
Kaposi's Sarcoma following Chronic Lymphocytic Leukemia: A Rare Entity. Case Rep Oncol (2012) 0.75
Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development (2000) 4.71
Antibiotic uptake by alveolar macrophages. J Lab Clin Med (1980) 4.69
The time-course of Ca2+ exchange with calmodulin, troponin, parvalbumin, and myosin in response to transient increases in Ca2+. Biophys J (1981) 4.47
Studies on lysosomes. XI. Characterization of a hydrolase-rich fraction from human lymphocytes. J Cell Biol (1968) 4.22
Nature of the surviving plaque-forming unit of reovirus in water containing bromine. Appl Microbiol (1975) 3.80
Initial fast reaction of bromine on reovirus in turbulent flowing water. Appl Environ Microbiol (1976) 3.78
Intracellular pH and activation of sea urchin eggs after fertilisation. Nature (1976) 3.72
Inactivation by bromine of single poliovirus particles in water. Appl Environ Microbiol (1976) 3.58
Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction. Clin Immunol Immunopathol (1973) 3.55
Localization of A antigen sites on human erythrocyte ghosts. Nature (1971) 2.99
Purification of human monocytes on microexudate-coated surfaces. J Immunol (1978) 2.86
The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest (1978) 2.83
Studies on human peripheral blood lymphocytes in vitro. II. Morphological and biochemical studies on the transformation of lymphocytes by pokeweed mitogen. J Exp Med (1966) 2.63
The IgG receptor: an immunological marker for the characterization of mononuclear cells. Immunology (1969) 2.46
Sheep red cell binding to human lymphocytes treated with neuraminidase; enhancement of T cell binding and identification of a subpopulation of B cells. J Exp Med (1973) 2.37
Physicochemical properties of rat testis Ca2+-dependent regulator protein of cyclic nucleotide phosphodiesterase. Relationship of Ca2+-binding, conformational changes, and phosphodiesterase activity. J Biol Chem (1977) 2.31
The effect of troponin I phosphorylation on the Ca2+-binding properties of the Ca2+-regulatory site of bovine cardiac troponin. J Biol Chem (1982) 2.27
Studies on human peripheral blood lymphocytes in vitro. I. Biological and physicochemical properties of the pokeweed mitogen. J Exp Med (1966) 2.27
A fluorescence stopped flow analysis of Ca2+ exchange with troponin C. J Biol Chem (1979) 2.21
Purification of human monocytes on gelatin-coated surfaces. J Immunol Methods (1986) 2.16
Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Haematol (2001) 2.10
Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol (1997) 2.08
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group. Am J Hematol (1988) 2.06
Human lymphocyte response to phytomitogens in vitro: normal, agammaglobulinemic and paraproteinemic individuals. J Immunol (1969) 2.05
Studies on human peripheral blood lymphocytes in vitro. 3. Fine structural features of lymphocyte transformation by pokeweed mitogen. J Immunol (1967) 2.03
UV inactivation of pathogenic and indicator microorganisms. Appl Environ Microbiol (1985) 1.91
The calcium and magnesium binding sites on cardiac troponin and their role in the regulation of myofibrillar adenosine triphosphatase. J Biol Chem (1980) 1.89
Polymerase chain reaction for detection of Toxoplasma gondii. J Med Microbiol (1990) 1.89
Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis (1984) 1.87
Myasthenia gravis. Lancet (1966) 1.82
Effect of ionic environment on the inactivation of poliovirus in water by chlorine. Appl Environ Microbiol (1980) 1.81
Posthemorrhagic hydrocephalus in low-birth-weight infants: treatment by serial lumbar punctures. J Pediatr (1980) 1.80
Parvalbumin content and Ca2+ and Mg2+ dissociation rates correlated with changes in relaxation rate of frog muscle fibres. J Physiol (1991) 1.76
Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. Leuk Res (2005) 1.73
Activation of Trp3 by inositol 1,4,5-trisphosphate receptors through displacement of inhibitory calmodulin from a common binding domain. Proc Natl Acad Sci U S A (2001) 1.70
Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J Clin Invest (1994) 1.70
CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation. Leukemia (2005) 1.70
Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65
A fluorescent probe study of Ca2+ binding to the Ca2+-specific sites of cardiac troponin and troponin C. J Biol Chem (1980) 1.65
Phosphorylation reverses the membrane association of peptides that correspond to the basic domains of MARCKS and neuromodulin. Biophys J (1994) 1.64
Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM. J Clin Pathol (1989) 1.61
The role of non-coding DNA sequences in transcription and processing of a yeast tRNA. Nucleic Acids Res (1983) 1.60
A non-x-linked syndrome with susceptibility to severe Epstein-Barr virus infections. J Pediatr (1982) 1.60
Hypoglycemia due to an insulin-binding monoclonal antibody in multiple myeloma. N Engl J Med (1992) 1.59
Disappearance and recovery of human monocyte IgG receptor activity after phagocytosis. J Immunol (1972) 1.59
Brain abscess. A study of 45 consecutive cases. Medicine (Baltimore) (1986) 1.58
Marrow transplantation in chronic granulomatous disease: an update, with 6-year follow-up. J Pediatr (1988) 1.57
Long-term human peripheral blood monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunology (1979) 1.55
The homeodomain of PDX-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter. Mol Cell Biol (2000) 1.55
IgG subclass specificity of human monocyte receptor sites. Nature (1971) 1.55
Granulocytopathies: pleomorphism of neutrophil dysfunction. Am J Med (1969) 1.54
Electron microscopic and functional aspects of human lymphocyte response to mitogens. Transplant Rev (1972) 1.54
Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial. Blood (1996) 1.54
Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J Clin Invest (1979) 1.54
Phosphorylation-regulated calmodulin binding to a prominent cellular substrate for protein kinase C. J Biol Chem (1989) 1.52
Human lymphocytes express substance P and its receptor. J Neuroimmunol (1998) 1.52
Transcription and processing of a yeast tRNA gene containing a modified intervening sequence. Proc Natl Acad Sci U S A (1980) 1.50
Clinical, serologic and leukocyte function studies on patients with idiopathic "acquired" agammaglobulinemia and their families. Am J Med (1970) 1.50
Notch signalling suppresses apoptosis in adult human and mouse pancreatic islet cells. Diabetologia (2007) 1.49
Reaction products of aquatic humic substances with chlorine. Environ Health Perspect (1982) 1.48
Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and Staphylococcus aureus infections. N Engl J Med (1979) 1.47
VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance. Leukemia (2005) 1.46
B-chronic lymphocytic leukemia cells contain both endogenous kappa immunoglobulin mRNA and critical immunoglobulin gene activation transcription factors. Leukemia (1992) 1.46
Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia (2000) 1.46
Multicenter experience with the Monarc transobturator sling system to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2005) 1.45
Human lymphocyte growth in vitro: morphologic, biochemical, and immunologic significance. Int Rev Exp Pathol (1971) 1.45
A defect in circulating mononuclear phagocytes in chronicgranulomatous disease of childhood. J Immunol (1968) 1.44
Difficulties in the diagnosis of congenital toxoplasmosis by cordocentesis. Case report. Br J Obstet Gynaecol (1991) 1.42
Neonatal hypoxia and pulmonary vasospasm: response to tolazoline. J Pediatr (1976) 1.41
The diagnosis of toxoplasmosis using IgG avidity. Epidemiol Infect (1994) 1.40
Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells. Microbiol Rev (1978) 1.39
In vivo modulation of yeast tRNA gene expression by 5'-flanking sequences. EMBO J (1985) 1.38
Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. Proc Natl Acad Sci U S A (2001) 1.36
Infection of cord blood monocyte-derived macrophages with human immunodeficiency virus type 1. J Virol (1992) 1.36
Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency. Blood (1992) 1.34
In vitro development of plasma cells from lymphocytes following pokeweed mitogen stimulation: a fine structural study. Exp Cell Res (1969) 1.34
Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate. Fundam Appl Toxicol (1984) 1.33
Hyperammonemia accompanying parenteral nutrition in newborn infants. J Pediatr (1972) 1.33
Overexpression of protein tyrosine kinases in human esophageal cancer. Pathobiology (1997) 1.32
Pulp revascularization of necrotic bilateral bicuspids using a modified novel technique to eliminate potential coronal discolouration: a case report. Int Endod J (2009) 1.30
Effect of temperature on relaxation rate and Ca2+, Mg2+ dissociation rates from parvalbumin of frog muscle fibres. J Physiol (1992) 1.28
The complex reaction kinetics of ECHO-1 virus with chlorine in water. Proc Soc Exp Biol Med (1977) 1.27
Isolation of highly purified human blood monocytes for in vitro HIV-1 infection studies of monocyte/macrophages. J Immunol Methods (1990) 1.27
Development of the premature infant's host defense system and its relationship to routine immunizations. Clin Perinatol (1984) 1.27
Reduction in perceived intensity of cutaneous stimuli during movement: a quantitative study. Exp Brain Res (1988) 1.26
Dynamics of the macrophage plasma membrane. Annu Rev Microbiol (1979) 1.26
Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro. Infect Immun (1985) 1.26
Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol (1975) 1.25
Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission. J Immunol (1999) 1.24
Selective inhibition of Na+-induced Ca2+ release from heart mitochondria by diltiazem and certain other Ca2+ antagonist drugs. J Biol Chem (1982) 1.24
Receptor sites on human monocytes for complement: binding of red cells sensitized by cold autoantibodies. Br J Haematol (1970) 1.23
Oxytocin and neonatal hyperbilirubinemia. Studies of bilirubin production. Am J Dis Child (1984) 1.23
Placental transfer of immunoglobulin G subclasses. Clin Diagn Lab Immunol (1994) 1.23
Quantitation of flecainide acetate, a new antiarrhythmic agent, in biological fluids by gas chromatography with electron-capture detection. J Pharm Sci (1984) 1.22
Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis (1990) 1.21
Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis. Blood (1998) 1.20
Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation. Blood (1981) 1.20